Evidence map›Paper›PMID 40984794›Full record

ArticleGut microbes2025

Mangesh Suryavanshi, Arthur Franklin, Sonia Fargue, Dean G Assimos, John Knight, Aaron W Miller

Abstract read
In one paragraph

Article in Gut microbes, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Mangesh SuryavanshiDepartment of Cardiovascular and Metabolic Sciences, Cleveland Clinic, Cleveland, OH, USA.
Arthur FranklinDepartment of Cardiovascular and Metabolic Sciences, Cleveland Clinic, Cleveland, OH, USA.
Sonia FargueDepartment of Urology, University of Alabama at Birmingham, Birmingham, AL, USA.
Dean G AssimosDepartment of Urology, University of Alabama at Birmingham, Birmingham, AL, USA.
John KnightDepartment of Urology, University of Alabama at Birmingham, Birmingham, AL, USA.
Aaron W MillerDepartment of Cardiovascular and Metabolic Sciences, Cleveland Clinic, Cleveland, OH, USA.ORCID 0000-0001-8342-1449

Funding

National Dissemination of I-Corps@NCATS: Accelerating Translation through CommercializationUL1TR003096 · NCATS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI GUTIERREZ, ORLANDO M, KIMBERLY, ROBERT P. · 2019 to 2023
$43.6M
Oxalobacter formigenes colonization and oxalate excretion in calcium oxalate kidney stone diseaseR01DK087967 · NIDDK · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI KNIGHT, JOHN · 2011 to 2020
$3.5M
Oxalate formation from ascorbic acidR01DK126774 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI KNIGHT, JOHN · 2021 to 2024
$2.5M
The role of acetogenic, methanogenic, and sulfate-reducing bacteria in oxalate metabolism and hyperoxaluriaR01DK121689 · NIDDK · CLEVELAND CLINIC LERNER COM-CWRU · PI MILLER, AARON W · 2020 to 2024
$2.3M
Obesity and Endogenous Oxalate SynthesisK08DK115833 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI WOOD, KYLE D · 2018 to 2022
$960k
Effect of weight loss on urinary oxalate excretion in obese calcium oxalate kidney stone formersR01DK128160 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI ASSIMOS, DEAN GEORGE · 2021 to 2023
$944k
Assessment of Endogenous Oxalate Synthesis in Calcium Oxalate Kidney Stone Formers and Healthy IndividualsR03DK129497 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI FARGUE, SONIA · 2021 to 2022
$199k
NCATS NIH HHS UL1 TR003096NIDDK NIH HHS K08 DK115833NIDDK NIH HHS R01 DK087967NIDDK NIH HHS R01 DK121689NIDDK NIH HHS R01 DK126774NIDDK NIH HHS R01 DK128160NIDDK NIH HHS R03 DK129497
6 · The paper itself

Abstract

Oxalate, a compound derived from both diet and metabolism, contributes to multiple renal and vascular diseases. Certain gut bacteria degrade oxalate, limiting absorption and promoting secretion. This study examined microbial factors that influence the effectiveness of

Indexed as

BacteriaGastrointestinal MicrobiomeOxalatesOxalobacter formigenesProbioticsAdultCarboxy-LyasesFecesFemaleHumansMaleMiddle AgedRNA, Ribosomal, 16SCarboxy-LyasesOxalatesoxalyl CoA decarboxylaseRNA, Ribosomal, 16ShyperoxaluriaOxalateoxalate-degrading bacteriaOxalobacter formigenesprobiotics

Identifiers

PMID40984794
PMCPMC12459359

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.